Tetanus

Definition

  • Acute disease characterised by general rigidity & convulsions caused by exotoxins produced in Clostridia tetani infections

Epidemiology

  • Annual world mortality now is 1 million
    • Britain 15/ year
    • USA 100/ year
    • Especially Rural areas

Aetiology & Pathology

  • Clostridium tetani
    • Gram positive Bacillus
    • Anaerobic
    • Spore-forming
  • Spores
    • Drumstick appearance (spores form at one end of the rod)
    • In faeces/ manure, dust & soil
    • Especially hot damp climates
    • Resistant to antiseptics & heat
    • » Autoclave for 10 minutes
  • Infection
    • Clostridium tetani is non-invasive
    • Occurs when spores enter tissues & produce vegetative forms
      • Entry through defect in epidermis
        • Puncture/ laceration
        • Surgery
        • Burns
        • Dental infection
        • Abortion
        • Childbirth
      • No history of wound in 20%
    • Germination in O2 poor media
      • Oxygen poor wounds
      • Foreign bodies
      • Infection
    • Infection remains localised » exotoxin spreads & produces effect
    • Spores may enter tissue & lie dormant with later activation
  • Tetanospasmin
    • Exotoxin released when vegetative bacteria lysed in wound
    • Potent Neurotoxin
      • 0.1mg lethal in Man
      • Spreads to CNS via PNS/ BV/ lymphatics
      • Blocks inhibitory pathways in cord
      • Muscle rigidity with paroxysmal spasms or convulsions result
      • Self-limiting
    • No residual effects
  • Tetanolysin
    • Haemolysin

Clinical Features

  • Mean incubation 1/52
    • 90% in < 15/7
    • Varies 2-60/7
  • Severity relates to rapidity of onset
  • Tetanus-prone wound
    • Open fracture
    • Puncture
    • Foreign body
    • Contamination
    • Tissue damage +++
    • > 6/52
    • Septic wound
    • Bite

Presenting symptoms

  • Pain & stiffness in
    • Jaw
    • Risus sardonicus
      • Clenched teeth expression
    • Abdomen
    • Back
    • Difficulty swallowing
  • Generalized rigidity
    • Trismus or lockjaw
    • Spinal extension & neck retraction
    • Upper limb flexed & lower limb extended
  • Reflex spasms
    • Follows at 24-72 hours
    • Due to external stimuli (eg. Noise)
    • May see laryngeal spasm » arrest
  • Sympathetic dysfunction
    • Seen only in severe cases
    • Hypertension, Tachycardia, Sweating
    • Arrhythmias, Ileus
  • Can last 3-6 weeks
  • Complications include
    • Hypoxia
    • Aspiration
    • Pneumonia
    • CV problems
    • Electrolyte abnormalities
    • Wedge fractures of vertebrae
    • Secondary infections
    • Hyperpyrexia
    • Bleeding problems – DIC & PUD
  • 20% no obvious cause of death

Complications

  • 60% die in 2/52
  • Spasms disappear by 1-3/52
  • If survive, recover by 6/52
  • Respiratory complications are major cause of death

Investigations

  • No specific tests
  • Clostridium tetani cultured from wound in 1/3

Prophylaxis

Active Primary Immunization

  • Tetanus toxin rendered non-toxic by formalin to produce tetanus vaccine
    • Tetanus toxoid (TT)
      • 0.5ml adsorbed toxoid
    • Triple antigen (CDT or ADT)
      • Diphtheria-Tetanus-Pertussis (previously called DPT)
  • Antibody production takes several weeks & protection lasts ~10 years

Primary Immunization in Children

  • Triple Antigen at 2, 4 & 6/12
  • CDT at 18/12 & 5 years
  • (EMST says 3 injections DPT then booster every 15 years)

Primary Immunization in Adult

  • Only for those never immunized
  • 3 courses of tetanus toxoid
    • 6/52 between 1st & 2nd
    • 6/12 between 2nd & 3rd
    • Should not repeat the full course
  • Booster
    • TT/ ADT booster every 10 years
    • If more than 20 years since booster then
      • 2 boosters of TT/ ADT with 4-6/52 interval between doses
  • Reactions include
    • Urticaria
    • Angiooedema
    • Diffuse indurated swelling at site of swelling

Passive Immunization

  • Tetanus Immunoglobulin (TIG)
  • 16% solution of gamma globulin fraction of donated plasma
  • Give in tetanus-prone wounds
    • If not immune
    • Never if immune
  • Dose is
    • 250 units IM
    • 500 units IM if wound grossly contaminated, result of burns, delay > 24 hrs
  • Into different limb from TT when giving both

Secondary Prophylaxis after Injury

  • If immunized » TT or ADT will produce protective antibodies in 1/7
  • If patient not immune » need full tetanus toxoid course
  • The following is EMST protocol

Patient previously fully immunised

  • Wound not Tetanus-prone
    • If < 10 years since TT » nothing
    • If > 10 years since TT » single TT
  • Wound Tetanus-prone
    • If < 5 years since TT » nothing
    • If > 5 years since TT » single TT

Patient not adequately immunised or unknown

  • Wound not Tetanus-prone
    • Give 0.5ml TT
  • Wound Tetanus-prone
    • Give 250-500 units TIG
    • + 0.5ml TT in other arm
    • ± penicillin

Treatment

  • Wound care
    • Debride necrotic & contaminated tissue
  • Antibiotics
    • Vegetative form sensitive to antibiotics
    • Tetanus spores destroyed by antibiotics at high doses
    • Use Penicillin G
      • 2 Million Units (1.2g) q4h for 10/7
    • If allergic to penicillin use
      • Erythromycin
      • Tetracycline
  • Antitoxin
    • Intravenous TIG is more concentrated TIG for treating clinical tetanus
      • 400-10 000 IU diluted with saline & given by infusion over 15 minutes
    • Neutralises the circulating toxin
    • Does not affect the toxins already fixed in CNS
    • Side effects include
      • Fever
      • Shivering
      • Chest or back pains
  • Other
    • Spasms control
      • Quiet dark room
      • Diazepam
      • Consider Thiopental infusion
    • Care of airway
      • Ventilation if
        • Severe spasms
        • Respiratory failure
        • ± Tracheostomy
    • Hydration & electrolytes monitored
    • Nutrition monitored
    • Sympathetic overactivity controlled by alpha & beta blockers

Contraindications

  • Only CI to TT is previous severe allergic reaction
  • Differentiate from allergy to hypersensitivity to tetanus antitoxin in horse serum
    • Passive immunisation
    • Withdrawn 30 years ago
    • Replaced by TIG
  • Differentiate TT allergy to TIG allergy
    • Give TIG if allergic to TT & tetanus-prone wound present

Prognosis

  • Related to severity of attack & assessed by
    • Incubation period
    • Onset time
    • Occurrence of spasms
    • Complications
    • Age of patient
  • Now mortality rate is 25% (vs 50% in past)